Relationships between polymorphisms of the human serum paraoxonase gene and insulin sensitivity in Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 60, Issue 2, 2003, Pages 79-85

  Ikeda, Yukio ^a   Suehiro, Tadashi ^a   Ohsaki, Fumiaki ^a   Arii, Kaoru ^a   Kumon, Yoshitaka ^a   Hashimoto, Kozo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Genetic polymorphism; Human serum paraoxonase; Insulin sensitivity; PON1

Indexed keywords

ARYLDIALKYLPHOSPHATASE; GENOMIC DNA; INSULIN;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE INFUSION; GLUCOSE INTOLERANCE; HUMAN; INSULIN SENSITIVITY; JAPAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROMOTER REGION;

EID: 0037405464     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00280-2     Document Type: Article

References (27)

1. Blatter M.-C., James R.W., Messmer S., Barja F., Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein- associated protein, K-45. Identity of K-45 with paraoxonase. Eur. J. Biochem. 211:1993;871-879.
2. Mackness M.I., Arrol S., Abbott C., Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135.
3. Adkins S., Gan K.N., Mody M., La Du B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52:1993;598-608.
4. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:1993;73-76.
5. Suehiro T., Nakamura T., Inoue M., et al. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. Atherosclerosis. 150:2000;295-298.
6. Leviev I., Kalix B., Brulhart Meynet M.-C., James R.W. The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients. Diabetologia. 44:2001;1177-1183.
7. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of diabetes mellitus. Report of a WHO Consultation, Geneva, World Health Organization, 1999.
8. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237:1979;E214-E223.
9. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
10. Hanson R.L., Ehm M.G., Pettitt D.J., et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am. J. Hum. Genet. 63:1998;1130-1138.
11. Mori Y., Otabe S., Dina C., et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p. Diabetes. 51:2002;1247-1255.
12. Inoue M., Suehiro T., Nakamura T., Ikeda Y., Kumon Y., Hashimoto K. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes. Metabolism. 49:2000;1400-1405.
13. Wolff S.P., Jiang Z.Y., Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic. Biol. Med. 10:1991;339-352.
14. Nourooz-Zadeh J., Tajaddini-Sarmadi J., McCarthy S., Betteridge D.J., Wolff S.P. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes. 44:1995;1054-1058.
15. Rudich A., Kozlovsky N., Potashnik R., Bashan N. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am. J. Physiol. 272:1997;E935-E940.
16. Tirosh A., Potashnik R., Bashan N., Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J. Biol. Chem. 274:1999;10595-10602.
17. Carantoni M., Abbasi F., Warmerdam F., et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler. Thromb. Vasc. Biol. 18:1998;762-767.
18. Mackness M.I., Arrol S., Mackness B., Durrington P.N. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet. 349:1997;851-852.
19. Aviram M., Billecke S., Sorenson R., et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 18:1998;1617-1624.
20. Cao H., Girard-Globa A., Berthezene F., Moulin P. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism. J. Lipid Res. 40:1999;133-139.
21. Ikeda Y., Suehiro T., Inoue M., et al. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. Matabolism. 47:1998;598-602.
22. Abbott C.A., Mackness M.I., Kumar S., Boulton A.J., Durrington P.N. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15:1995;1812-1818.
23. Itahara T., Suehiro T., Ikeda Y., et al. Serum paraoxonase and arylesterase activities in hemodialysis patients. J. Atheroscler. Thromb. 7:2000;152-158.
24. Suehiro T., Ikeda Y., Shiinoki T., et al. Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis. J. Atheroscler. Thromb. 9:2002;133-138.
25. Navab M., Hama-Levy S., Van Lenten B.J., et al. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J. Clin. Invest. 99:1997;2005-2019.
26. Van Lenten B.J., Wagner A.C., Navab M., Fogelman A.M. Oxidized phospholipids induce changes in hepatic paraoxonase and apoJ but not monocyte chemoattractant protein-1 via interleukin-6. J. Biol. Chem. 276:2001;1923-1929.
27. Yamada A., Shoji T., Tahara H., Emoto M., Nishizawa Y. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population. Metabolism. 50:2001;805-811.